WAKEFIELD, Mass. -- Agion Technologies announces that three of its leading-edge partners have recently launched products in the healthcare market, further expanding the use of antimicrobial-treated products in the healthcare setting. The products include everything from catheters to hardware to medical slings.
Vygon, a leading manufacturer of integrated single and multi-lumen central venous catheters, has received a Food and Drug Administration (FDA) 510(k) Premarket Notification for its Multicath Expert line of antimicrobial vascular catheters, featuring Agion technology, which reduces the colonization of microbes on the surface of the device.
Another Agion partner, Foss Manufacturing, a leader and pioneer in the use of non-woven fabrics and specialty synthetic fibers, has incorporated their Fosshield line of antimicrobial fiber into slings used within the healthcare setting to aid in the transport of immobilized patients. As slings are often used on many different patients over a short period of time, the incorporation of Agion antimicrobial technology into the sling reduces the growth of destructive bacteria between cleanings.
A third Agion partner and leading manufacturer of door security solutions, Assa Abloy, has made headlines recently for being included in WashingtonHospitals newly built ER One, a state of the art, all-risks ready, emergency care facility. Assa Abloys door handles, frames and hardware are being utilized to reduce microbial growth on high touch surfaces where the touch transfer of bacteria is of particular concern. We have seen widespread adoption of the Agion treated hardware in leading healthcare environments across the U.S. and Europe, said Robb Tibbling, director of business development for Assa Abloy.
Other products, such as Agions SilverClene24, are becoming the top choice of infection control professionals nationwide in the fight to control the spread of methicillin-resistant Staphylococcus aureus (MRSA) within the healthcare environment Silverclene24 was the subject of a study conducted by Maureen Spencer, head of infection control for New England Baptist Hospital, and presented at the Association for Professionals in Infection Control and Epidemiology (APIC) conference in June 2007.
The headlines about infection rates in hospitals, and MRSA emerging in schools are creating a heightened level of awareness about the spread of bacteria, said Ginger Merritt, vice president of sales and marketing for Agion.
Source: Agion Technologies, Inc.